Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles British Journal of Haematology Year : 2022

Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease

Abstract

Given the lack of information about safety of the COVID-19 vaccines for sickle cell disease (SCD) patients, we sought to determine whether COVID-19 vaccine was associated with subsequent hospital admission for vaso-occlusive events (VOEs). We included 402 patients with SCD, including 88 regularly transfused. As of July 31, 2021, 213 (53.0%) of them had received a least one dose of COVID vaccine (Pfizer 93.0%). We showed similar risk of hospital admission for a VOE among vaccinated patients (whether transfused or not) and among a control group of non-vaccinated patients matched for age, sex and genotype.

Dates and versions

hal-03911627 , version 1 (23-12-2022)

Identifiers

Cite

Laure Joseph, Anne Corbasson, Sandra Manceau, Djamal Khimoud, Benoit Meunier, et al.. Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease. British Journal of Haematology, In press, ⟨10.1111/bjh.18547⟩. ⟨hal-03911627⟩
35 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More